))
Episode 19 - The Next Generation of Cell & Gene Therapies
Manage episode 445729478 series 3609046
Contenido proporcionado por BioTalent Social. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BioTalent Social o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Our BioTalent Social community came together for an informative discussion on ‘The Next Generation of Cell & Gene Therapies,’ hosted by our very own James Hume. The discussion touched on a multitude of topical themes and insights, including:
- The role of tech-transfer offices in turning early-stage interventions into products
- Current challenges and opportunities for CGT start-ups in Europe
- The complexities of clinical trials, and how we can make this smoother
- PHDs: the importance of scientific and entrepreneurial learning
- Viral vs. non-viral vectors
- Mindset in CGT: the importance of resilience, perseverance and ambiguity tolerance
Thank you to our wonderful panel members Stephen Sullivan, Kerstin Papenfuss and John Counsell for their sharp and focussed insights.
21 episodios
Compartir
